We exist to improve the lives
of everyone affected by epilepsy

Stories about EMA

EMA public hearing on valproate-based medicines open for applications from EU citizens

14 Jul 2017

The European Medicines Agency (EMA) is holding a public hearing on medicines containing valproate on 26 September 2017 at its London offices.

The EMA assesses and oversees the safety of medicines in the EU. The announced public hearing is part of the EMA’s review into the use of valproate-based medicines in women who are pregnant or of childbearing age.

Subscribe to EMA